Skip to main content

Table 1 Characteristic of 30 patients

From: Early assessment by FDG-PET/CT of patients with advanced renal cell carcinoma treated with tyrosine kinase inhibitors is predictive of disease course

Age (year)

32-80 (mean 64)

Gender

 

 Male

25

 Female

5

Histology

 

 Clear cell

23

 Papillary

5

 Clear/Sarcomatoid

1

 Clear/Papillary

1

TKI treatment

 

 Sunitinib

16

 Sorafenib

14

MSKCC classification

 

 Favorable

1

 Intermediate

21

 Poor

8

Nephrectomy

 

 Yes

22

 No

8

Prior treatment

 

 Non

19

 IFN-α

9

 Sorafenib

3

 Chemotherapy

2